CYP1A2 Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of CYP1A2 monoclonal antibodies for research focused on understanding this important enzyme. CYP1A2 monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CYP1A2 is a member of the cytochrome P450 family of enzymes, primarily involved in the metabolism of drugs and the activation of procarcinogens. CYP1A2 plays a crucial role in the biotransformation of various xenobiotics and endogenous compounds, influencing pharmacokinetics and toxicology. Understanding CYP1A2 function is essential for drug development and assessing individual responses to medications. CYP1A2 research has revealed significant insights into drug metabolism pathways and their impact on therapeutic outcomes. Ongoing studies continue to uncover new aspects of CYP1A2's role in metabolic processes and drug interactions. Research utilizing CYP1A2 monoclonal antibodies has enhanced our understanding of individual variations in drug responses and metabolism. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific knowledge in drug metabolism and therapeutic development.